349 related articles for article (PubMed ID: 27283333)
41. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
Jacobsson LT; Turesson C; Gülfe A; Kapetanovic MC; Petersson IF; Saxne T; Geborek P
J Rheumatol; 2005 Jul; 32(7):1213-8. PubMed ID: 15996054
[TBL] [Abstract][Full Text] [Related]
42. Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmö, Sweden.
Bergström U; Jacobsson LT; Turesson C
Rheumatology (Oxford); 2009 Dec; 48(12):1600-5. PubMed ID: 19858122
[TBL] [Abstract][Full Text] [Related]
43. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
[TBL] [Abstract][Full Text] [Related]
44. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
Ajeganova S; Andersson ML; Frostegård J; Hafström I
J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
[TBL] [Abstract][Full Text] [Related]
45. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
[TBL] [Abstract][Full Text] [Related]
46. Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
Eriksson JK; Johansson K; Askling J; Neovius M
Ann Rheum Dis; 2015 Apr; 74(4):648-54. PubMed ID: 24323395
[TBL] [Abstract][Full Text] [Related]
47. Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.
Arts EE; Fransen J; Den Broeder AA; van Riel PLCM; Popa CD
Ann Rheum Dis; 2017 Oct; 76(10):1693-1699. PubMed ID: 28606965
[TBL] [Abstract][Full Text] [Related]
48. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
[TBL] [Abstract][Full Text] [Related]
49. Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.
Ljung L; Simard JF; Jacobsson L; Rantapää-Dahlqvist S; Askling J;
Arthritis Rheum; 2012 Jan; 64(1):42-52. PubMed ID: 21898355
[TBL] [Abstract][Full Text] [Related]
50. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.
Castañeda S; González-Juanatey C; González-Gay MA
Clin Rev Allergy Immunol; 2019 Jun; 56(3):278-292. PubMed ID: 28852999
[TBL] [Abstract][Full Text] [Related]
51. Time trends in incidence, clinical features, and cardiovascular disease in ankylosing spondylitis over three decades: a population-based study.
Wright KA; Crowson CS; Michet CJ; Matteson EL
Arthritis Care Res (Hoboken); 2015 May; 67(6):836-41. PubMed ID: 25384671
[TBL] [Abstract][Full Text] [Related]
52. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
Arts EE; Popa C; Den Broeder AA; Semb AG; Toms T; Kitas GD; van Riel PL; Fransen J
Ann Rheum Dis; 2015 Apr; 74(4):668-74. PubMed ID: 24389293
[TBL] [Abstract][Full Text] [Related]
53. Differences and similarities between ankylosing spondylitis and rheumatoid arthritis: epidemiology.
Cross MJ; Smith EU; Zochling J; March LM
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S36-42. PubMed ID: 19822044
[TBL] [Abstract][Full Text] [Related]
54. The impact of inflammatory rheumatic diseases on the presentation, severity, and outcome of acute coronary syndrome.
Ben-Zvi I; Goldenberg I; Matetzky S; Grossman C; Elis A; Gavrielov-Yusim N; Livneh A
Clin Rheumatol; 2016 Jan; 35(1):233-7. PubMed ID: 24928341
[TBL] [Abstract][Full Text] [Related]
55. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.
Lauper K; Courvoisier DS; Chevallier P; Finckh A; Gabay C
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1756-1763. PubMed ID: 29609199
[TBL] [Abstract][Full Text] [Related]
56. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
57. Mortality in ankylosing spondylitis: results from a nationwide population-based study.
Exarchou S; Lie E; Lindström U; Askling J; Forsblad-d'Elia H; Turesson C; Kristensen LE; Jacobsson LT
Ann Rheum Dis; 2016 Aug; 75(8):1466-72. PubMed ID: 26338036
[TBL] [Abstract][Full Text] [Related]
58. Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries.
Delcoigne B; Ljung L; Provan SA; Glintborg B; Hetland ML; Grøn KL; Peltomaa R; Relas H; Turesson C; Gudbjornsson B; Michelsen B; Askling J
Ann Rheum Dis; 2022 Jun; 81(6):789-797. PubMed ID: 35318218
[TBL] [Abstract][Full Text] [Related]
59. Acute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study.
Leclair V; Svensson J; Lundberg IE; Holmqvist M
J Rheumatol; 2019 Nov; 46(11):1509-1514. PubMed ID: 30877220
[TBL] [Abstract][Full Text] [Related]
60. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
